Výsledky vyhledávání - "McElligott S"

Akademický článek

Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers

Autor: Hajiebrahimi M, Linder M, Hägg D, Anveden Berglind I, McElligott S, Valgardsson VS, Villacorta R, Sundström A

Publikováno v: Clinical Epidemiology, Vol Volume 10, Pp 705-715 (2018)

Mohammadhossein Hajiebrahimi,1,2 Marie Linder,1 David Hägg,1 Ina Anveden Berglind,1 Sean McElligott,3 Valgard Sverrir Valgardsson,4 Reginald Villacorta,3 Anders Sundström1 1Center for Pharmacoepidemiology, Department of Medicine, Karolinska Institu

Externí odkaz: https://doaj.org/article/df359d14005e4395a5f47500832bb14b

Zobrazit plný text záznamu

Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis

Autor: Diels, J, Thilakarathne, P, Cameron, C, McElligott, S, Schubert, A, Puig, L

Publikováno v: BRITISH JOURNAL OF DERMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background Guselkumab is an interleukin-23 inhibitor indicated for the treatment of moderate-to-severe plaque psoriasis in adults. Guselkumab has demonstrated additional benefit in patients with early inadequate response to ustekinumab. Long-term eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a1647f5ba486a4b74079a049b72cbcef
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1531